Bessemer Group
RAPT

Bessemer Group’s RAPT Therapeutics RAPT Stock Holding History

Bessemer Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11
Closed – – 2653
2025
Q4 		$0 Hold
11
– – ﹤0.01% 2677
2025
Q3 		$0 Buy
+11
New +$144 ﹤0.01% 2680

Bessemer Group's RAPT Position: Q1 2026 in Review

Bessemer Group sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 11 shares.

Bessemer Group first reported a position in RAPT in Q3 2025 and held it in 2 quarters. The position peaked at $0 in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

  • Bessemer Group reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bessemer Group sold 11 RAPT Therapeutics shares in Q1 2026.
  • Bessemer Group first reported a position in RAPT Therapeutics in Q3 2025 and held it in 2 quarters.
  • Bessemer Group's RAPT Therapeutics position peaked at $0 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.